{
  "id": 7604685,
  "title": "Nektar Therapeutics options flow shows bullish bets against a bearish tape",
  "url": "https://urgent.news/2026/09/15/nektar-therapeutics-options-flow-shows-bullish-bets-against-a-bearish",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-09-15T18:19:57.000Z",
  "source": {
    "name": "Investing.com",
    "slug": "investing-com",
    "url": "https://www.investing.com/news/stock-market-news/nektar-therapeutics-options-flow-shows-bullish-bets-against-a-bearish-tape-93CH-4902386"
  },
  "original_language": "en",
  "account": "On September 15, Nektar Therapeutics (NKTR) options flow revealed a stark contrast between bearish market sentiment and bullish bets. The call/put ratio stood at an unprecedented 27.5:1, with 3,082 calls versus 112 puts. Despite the stock's sharp decline of -3.38% to $66.185, this bullish tilt persisted. The Jan 15, 2027 $70 call option, initiated by Wedbush with a Neutral price target, was the most active, indicating confidence in the firm's bullish stance. Interestingly, 3-month implied volatility dropped 1.95 percentage points to 74.12%, suggesting market participants were less concerned about further declines. This aligns with the collapsing 90/110 skew, indicating diminishing demand for tail-risk hedging. The options market's optimism clashes with the stock's Strong Sell signals across all short-term timeframes. The weekly chart even displayed an Advance Block Bearish pattern, a strong exhaustion signal. Despite this, the Jan 2027 long-dated calls demonstrate substantial conviction, with Q2 2026 EPS beat and $373.8M raised in April to fund Phase 3 trials. The options market, therefore, is betting on today's pain potentially becoming tomorrow's entry point, provided the stock rebounds and holds.",
  "summary": null,
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}